DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OXYTOCIN 10 USP UNITS IN DEXTROSE 5%

« Back to Dashboard

All Clinical Trials for Oxytocin 10 Usp Units In Dextrose 5%

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004363	Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus	Completed	Northwestern University	N/A	1995-12-01	OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently.
NCT00004363	Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus	Completed	National Center for Research Resources (NCRR)	N/A	1995-12-01	OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently.
NCT00107874	Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-Scheduled Cesarean Section	Completed	Basel Women’s University Hospital	Phase 2	1999-01-01	Postpartum hemorrhage (PPH) ranks among the leading causes of maternal morbidity and mortality, both in developed and developing countries. With this trial, we sought to determine the effectiveness of oral misoprostol as an uterotonic drug in comparison with intravenous oxytocin, in patients with a low risk of PPH undergoing non-scheduled Cesarean section. We therefore compared the intra- and postoperative blood loss, as well as drug related side effects in patients, treated by the same surgical and anesthesiological team in one institution.
NCT00114439	Lithium Cannabis Withdrawal Study	Completed	The University of New South Wales	Phase 2	2005-09-01	This trial will examine the efficacy of lithium in providing symptomatic relief from the withdrawal discomfort experienced by some dependent users of cannabis on cessation of regular use. Significant withdrawal may be a barrier to achieving abstinence in some clients and can be associated with marked disturbances in mood, sleep, hostility and aggression. Relief from such symptoms may be important in helping some clients achieve a period of abstinence and facilitate subsequent entry into a relapse prevention program.
NCT00114439	Lithium Cannabis Withdrawal Study	Completed	Sydney South West Area Health Service	Phase 2	2005-09-01	This trial will examine the efficacy of lithium in providing symptomatic relief from the withdrawal discomfort experienced by some dependent users of cannabis on cessation of regular use. Significant withdrawal may be a barrier to achieving abstinence in some clients and can be associated with marked disturbances in mood, sleep, hostility and aggression. Relief from such symptoms may be important in helping some clients achieve a period of abstinence and facilitate subsequent entry into a relapse prevention program.

Clinical Trial Conditions for Oxytocin 10 Usp Units In Dextrose 5%

Condition Name

Condition Name for Oxytocin 10 Usp Units In Dextrose 5%
Intervention	Trials
Postpartum Hemorrhage	66
Healthy	37
Schizophrenia	28
Pregnancy	13

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Oxytocin 10 Usp Units In Dextrose 5%
Intervention	Trials
Hemorrhage	113
Postpartum Hemorrhage	111
Schizophrenia	31
Disease	31

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Oxytocin 10 Usp Units In Dextrose 5%

Trials by Country

Trials by Country for Oxytocin 10 Usp Units In Dextrose 5%
Location	Trials
United States	283
Canada	54
Egypt	44
China	31
France	28

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Oxytocin 10 Usp Units In Dextrose 5%
Location	Trials
California	57
New York	28
Massachusetts	22
North Carolina	21
Maryland	17

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Oxytocin 10 Usp Units In Dextrose 5%

Clinical Trial Phase

Clinical Trial Phase for Oxytocin 10 Usp Units In Dextrose 5%
Clinical Trial Phase	Trials
Phase 4	96
Phase 3	57
Phase 2/Phase 3	13

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Oxytocin 10 Usp Units In Dextrose 5%
Clinical Trial Phase	Trials
Completed	224
Recruiting	148
Not yet recruiting	106

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Oxytocin 10 Usp Units In Dextrose 5%

Sponsor Name

Sponsor Name for Oxytocin 10 Usp Units In Dextrose 5%
Sponsor	Trials
University of Electronic Science and Technology of China	26
Samuel Lunenfeld Research Institute, Mount Sinai Hospital	25
University of California, San Francisco	15

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Oxytocin 10 Usp Units In Dextrose 5%
Sponsor	Trials
Other	718
Industry	36
NIH	30

Export unavailable in trial.
Subscribe for complete access.